Kelly Langdon
ANALYST APPLICATION PHARMACIST at HOUSTON HOSPITALS INC · GA · Healthcare
$173K
Peak Total Compensation
2
Years Tracked
2x
vs. Median Household
Kelly Langdon has appeared in compensation disclosures over 2 years of available data (2020–2022). Total compensation changed from $173,533 to $158,800 - a -8.5% change.
Peak total compensation of $172,875 equals 2x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2022 | HOUSTON HOSPITALS INC | ANALYST APPLICATION PHARMACIST | $154,986 | $3,100 | $158,086 |
| 2020 | HOUSTON HOSPITALS INC | PHARMACIST | $169,634 | $3,241 | $172,875 |
Peers at HOUSTON HOSPITALS INC
| Name | Title | Peak Comp. |
|---|---|---|
| Luke Couch | PHYSICIAN | $749K |
| Cary Martin | CEO (TERM ENDING 2019) | $495K |
| Charles G Briscoe | PRESIDENT & CHIEF EXEC. OFFICER | $466K |
| Larry D Stewart Md | VP & CHIEF MEDICAL OFFICER | $394K |
| Charles Briscoe | PRESIDENT & CEO (TERM BEG. 2019) | $386K |
| Latoya D Jackson | PHYSICIAN | $375K |
| Sean S Whilden | VP & CFO (INTERIM COO) | $341K |
| Charles Nutinsky Do | CMO (FORMER) | $337K |
| Juan Valazquez | PHYSICIAN | $335K |
| Peter Izzo | PHYSICIAN | $323K |
Email Alerts
Get notified about Kelly Langdon
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →